SCHEMBL10015405

SCHEMBL10015405

c1ccc(-c2cc(-c3ccc4c5c(-c6ccc7ccccc7c6)c6c(cc7c8ccccc8c8cccc6c87)c(-c6ccc7ccccc7c6)c5c5cccc3c54)cc(-c3ccccc3)n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A1 P04798 1/20 0.39
▸ CYP1B1 Q16678 1/20 0.39
▸ CTRC Q99895 1/20 0.34
▸ KDM4E B2RXH2 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ PIM1 P11309 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ ACACA Q13085 3/20 0.33
▸ CYP1A2 P05177 4/20 0.32
▸ ALOX5 P09917 1/20 0.32
▸ GPR84 Q9NQS5 1/20 0.31
▸ IKBKB O14920 1/20 0.31
▸ HSD17B1 P14061 1/20 0.31
▸ HSD17B2 P37059 1/20 0.31
▸ CYP2C19 P33261 2/20 0.31
▸ HIF1A Q16665 2/20 0.31
▸ CYP2D6 P10635 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25005766 0.88 MEN1 (0.36) CYP1A1CYP1B1CTRCPIM1ACACA
SCHEMBL25006625 0.88 MEN1 (0.36) CYP1A1CYP1B1CTRCPIM1ACACA
SCHEMBL14700535 0.86 CYP1A1 (0.38) CYP1A1CYP1B1CTRCKDM4EALDH1A1
SCHEMBL10046350 0.82 MEN1 (0.30) MEN1KMT2A
SCHEMBL10015419 0.81 MEN1 (0.35) KDM4EALDH1A1MAPTHPGDCYP1A2
SCHEMBL23349048 0.79 KDM1A (0.37) PIM1GPR84MEN1KMT2A
SCHEMBL23349018 0.79 KDM1A (0.37) PIM1GPR84MEN1KMT2A
SCHEMBL22916738 0.78 CYP11B1 (0.38) KDM4EALDH1A1PIM1MAPTCYP1A2
SCHEMBL25005767 0.78 CYP11B1 (0.38) KDM4EALDH1A1PIM1MAPTCYP1A2
SCHEMBL22652712 0.78 ERN1 (0.35) CYP1A2GPR84HSD17B1HSD17B2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190245152-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2019-08-08 — — US disclosed
US-9315460-B2 Organic compound, light-emitting device, and image display apparatus CANON KABUSHIKI KAISHA (JP) 2016-04-19 — — US disclosed
US-9315460-B2 Organic compound, light-emitting device, and image display apparatus CANON KABUSHIKI KAISHA (JP) 2016-04-19 — — US disclosed
US-8940413-B2 Organic compound having acenaphtho[1,2-k]benzo[e]acephenanthrene derivative, light-emitting device, and image display apparatus CANON KABUSHIKI KAISHA (JP) 2015-01-27 — — US disclosed
US-20140374738-A1 NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS CANON KK (JP) 2014-12-25 — — US disclosed
US-20140374738-A1 NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS CANON KK (JP) 2014-12-25 — — US disclosed
US-20120025183-A1 NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS CANON KABUSHIKI KAISHA (JP) 2012-02-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120025183-A1 NOVEL ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND IMAGE DISPLAY APPARATUS ACE, ACE2, AGTR1 CYP1A1 28/4885CYP1B1 99/4885CTRC 317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback